Treatment for systemic sclerosis-associated interstitial lung disease.
Roofeh D, Lescoat A, Khanna D.
Curr Opin Rheumatol. 2021 May 1;33(3):240-248. doi: 10.1097/BOR.0000000000000795.
PMID:33741803
Interstitial lung disease associated with systemic sclerosis (SSc-ILD).
Cottin V, Brown KK.
Respir Res. 2019 Jan 18;20(1):13. doi: 10.1186/s12931-019-0980-7.
PMID:30658650
Interstitial lung disease in systemic sclerosis: a simple staging system.
Goh NS, Desai SR, Veeraraghavan S, Hansell DM, Copley SJ, Maher TM, Corte TJ, Sander CR, Ratoff J, Devaraj A, Bozovic G, Denton CP, Black CM, du Bois RM, Wells AU.
Am J Respir Crit Care Med. 2008 Jun 1;177(11):1248-54. doi: 10.1164/rccm.200706-877OC. Epub 2008 Mar 27.
PMID:18369202
Interstitial Lung Disease in Systemic Lupus Erythematosus and Systemic Sclerosis: How Can We Manage the Challenge?
Richter P, Cardoneanu A, Dima N, Bratoiu I, Rezus C, Burlui AM, Costin D, Macovei LA, Rezus E.
Int J Mol Sci. 2023 May 28;24(11):9388. doi: 10.3390/ijms24119388.
PMID:37298342
Predictors of progression in systemic sclerosis patients with interstitial lung disease.
Distler O, Assassi S, Cottin V, Cutolo M, Danoff SK, Denton CP, Distler JHW, Hoffmann-Vold AM, Johnson SR, Müller Ladner U, Smith V, Volkmann ER, Maher TM.
Eur Respir J. 2020 May 14;55(5):1902026. doi: 10.1183/13993003.02026-2019. Print 2020 May.
PMID:32079645
Current advances in the treatment of systemic sclerosis.